First phase of clinical trials of Kazakhstani vaccine against coronavirus to start in September
Astana. August 10. KazTAG - The first phase of clinical trials of Kazakhstani vaccine against the coronavirus is planned to start in September, reports the press service of the Ministry of Education and Science.
“The results of preclinical tests of the inactivated vaccine were sent to the National Center for Expertise of Medicines, which will is expected to be completed by mid-August. After obtaining permission from the Ministry of Health Care, the first phase of clinical trials at the Almaty clinic is expected to begin in September on 44 volunteers aged from 18 to 50 who do not have antibodies to COVID-19. After vaccination, they will be patronized for 42 days. Further, in mid-October, it is planned to begin the second phase of clinical trials, which should be completed in December 2020, " reads the report.
According to the Ministry of Education and Science, with positive results of clinical trials of vaccines, Kazakhstan will produce vaccines at currently constructed biopharmaceutical plant at the Scientific Research Institute of Biological Safety Problems in the village of Otar, Zhambyl region.
"It is planned that the plant will produce immune-biological drugs according to the international standard, including vaccines for COVID-19, which are now being preclinical tested by Kazakhstani scientists," reads the report.
Photo source: picture from an open source